Botox, commonly used as the leading non-surgical cosmetic treatment in the United States for minimizing the appearance of fine lines and wrinkles, has also been associated with reducing the risk of arrhythmia in surgical patients.
Those undergoing open-heart surgery are more prone to suffer from an irregular heartbeat. This raises the odds of developing a stroke or heart failure if you’re already at risk. Injecting Botox into the epicardial fat pads at the time of surgery, however, has been shown to reduce the risk of irregular heartbeat for up to a year after heart surgery.
Although Botox has gained popularity as a cosmetic treatment, it was originally licensed by the FDA as a medical medication for the treatment of ocular spasms. A number of years later, the Food and Drug Administration (FDA) gave its blessing for its use in combating crow’s feet and other aging symptoms.
Botox temporarily reduces the range of motion of the injected muscle.
Those participants in this tiny trial who had Botox injections into the heart muscle had a smooth surgical procedure. Furthermore, they did not have the same incidence of arrhythmias as those patients who did not get Botox.
Many medical and aesthetic procedures have found success with the use of Botox. The results of this study demonstrate that it has maintained its popularity throughout the past decade.